Medtronic Neuromodulation has recalled 118 Wireless Recharger Kits because the rechargers may be unable to start a recharging session upon first use. This issue affects the RS6230, RS7230, and RS5220A kits used with Deep Brain Stimulation and Pelvic Health implantable neurostimulators. These products were distributed worldwide, including in 18 U.S. states and 15 countries, primarily through authorized medical distributors and hospitals.
If the wireless recharger fails to function, patients with implanted neurostimulators may be unable to maintain their therapy levels. This can lead to a loss of symptom control or potentially serious health complications depending on the specific condition being treated.
Contact your healthcare provider or Medtronic for instructions.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.